XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance

BACKGROUND: DNA repair pathways are used by cancer cells to overcome many standard anticancer treatments, causing therapy resistance. Here, we investigated the role of XRCC4-like factor (XLF), a core member of the non-homologous end joining (NHEJ) repair pathway, in chemoresistance in hepatocellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sitian, Wang, Xiao Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437682/
https://www.ncbi.nlm.nih.gov/pubmed/28526069
http://dx.doi.org/10.1186/s12885-017-3345-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437682/
https://www.ncbi.nlm.nih.gov/pubmed/28526069
http://dx.doi.org/10.1186/s12885-017-3345-y

Ejemplares similares